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The transcription factor GATA3 is crucial for the
differentiation of naive CD4+ T cells into T helper 2
(Th2) cells. Here, we show that deletion of Gata3
allowed the appearance of interferon-g (IFN-g)-pro-
ducing cells in the absence of interleukin-12 (IL-12)
and IFN-g. Such IFN-g production was transcription
factor T-bet independent. Another T-box-containing
transcription factor Eomes, but not T-bet, was
induced both in GATA3-deficient CD4+ T cells differ-
entiated under Th2 cell conditions and in Th2 cells
with enforced Runx3 expression, contributing to
IFN-g production. GATA3 overexpression blocked
Runx3-mediatedEomes induction and IFN-gproduc-
tion, and GATA3 protein physically interacted with
Runx3 protein. Furthermore, we found that Runx3
directly bound to multiple regulatory elements of the
Ifng gene and that blocking Runx3 function in either
Th1 or GATA3-deficient ‘‘Th2’’ cells results in dimin-
ished IFN-g production by these cells. Thus, the
Runx3-mediated pathway, actively suppressed by
GATA3, induces IFN-g production in a STAT4- and
T-bet-independent manner.
INTRODUCTION
Naive CD4+ T cells differentiate into at least four types of T helper
(Th) cells, including Th1 cells, Th2 cells, inducible T regulatory
cells and Th17 cells. Th1 cells produce cytokines, such as IFN-
g and lymphotoxin alpha, and activate macrophages and CD8+
T cells to induce immunity against intracellular pathogens,
whereas Th2 cells produce signature cytokines, interleukin-4
(IL-4), IL-5, IL-9, and IL-13, that are involved in host defense
against extracellular pathogens such as helminths (Ansel et al.,
2006; Murphy and Reiner, 2002; Zhu and Paul, 2008). Differenti-
ation fate is determined by several factors, including the nature
and dose of antigen, the type of costimulation, and the cytokine
milieu.
Both IFN-g and IL-12 play important roles in Th1 differentia-
tion. The capacity of T cells to produce IFN-g is programmedby various transcription factors, including STAT4, two T-box
protein family members, T-bet and Eomesodermin (Eomes),
and Runx3. STAT4 is activated by IL-12; STAT4-deficient CD4+
T cells have a defect in IFN-g production (Jacobson et al.,
1995; Kaplan et al., 1996; Thierfelder et al., 1996; Watford
et al., 2004). T-bet is induced mainly through an IFN-g-STAT1-
dependent pathway (Afkarian et al., 2002; Lighvani et al.,
2001), but the IL-12-STAT4 pathway also contributes to T-bet
upregulation (Yang et al., 2007). T-bet not only promotes Th1
cell differentiation but also represses Th2 cell differentiation by
suppressing GATA3 expression (Usui et al., 2006) and reducing
the binding of GATA3 to DNA (Hwang et al., 2005; Szabo et al.,
2000). T-bet-deficient (Tbx21/) ‘‘Th1’’ cells and Tbx21/ NK
cells produce less IFN-g than do wild-type (WT) cells. Although
T-bet deficiency does not affect IFN-g production by CD8+
T cells in vitro (Szabo et al., 2002), it results in reduced numbers
of IFN-g-producing antigen-specific CD8+ T cells in response to
LCMV infection (Intlekofer et al., 2007; Joshi et al., 2007). Pearce
et al. (2003) reported that IFN-g production by Tbx21/ CD8+
T cells in vitro was dependent on the expression of Eomes.
Runx3, a critical transcription factor for silencing CD4 expres-
sion during T cell development (Taniuchi et al., 2002), has been
reported to be expressed at higher amount in Th1 cells than in
Th2 cells (Djuretic et al., 2007; Naoe et al., 2007). Runx3
enhances IFN-g production, although the detailed mechanism
through which it does so is not clear (Djuretic et al., 2007). In
addition, Runx3 has been reported to directly repress IL-4 tran-
scription by binding, in collaboration with T-bet, to the DNase I
hypersensitivity (HS) IV region of the Il4 gene (Djuretic et al.,
2007). Runx3fl/fl-CD4-Cre mice spontaneously show an asthma-
like phenotype, including increased serum IgE and infiltration
of lymphoid cells in the lung and bronchoaveolar lavage fluid,
implying that Runx3 is also important for repressing Th2
responses (Naoe et al., 2007).
IL-4 and IL-2 are indispensable for in vitro Th2 differentiation
(Cote-Sierra et al., 2004; Yamane et al., 2005; Zhu et al., 2003).
The regulation of Th2 differentiation and of the capacity of
these cells to produce Th2 cytokines depends on several tran-
scription factors, including STAT5, STAT6, and GATA3 (Zhu
et al., 2006). GATA3, the ‘‘master’’ transcription factor for Th2
differentiation, is upregulated both by TCR stimulation and
IL-4-STAT6 signaling (Ouyang et al., 1998; Zheng and Flavell,
1997). By contrast, GATA3 expression is diminished during
Th1 differentiation. Enforced GATA3 expression in developingImmunity 32, 507–517, April 23, 2010 ª2010 Elsevier Inc. 507
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GATA3 Suppresses Runx3-Mediated IFN-g ProductionTh1 cells induces IL-4-producing capacity. The importance of
GATA3 expression during Th2 differentiation, both in vitro and
in vivo, has been confirmed utilizing GATA3-conditionally-defi-
cient mice (Pai et al., 2004; Zhu et al., 2004). These experiments
showed that GATA3 is critical for promoting Th2 cell expansion,
as well as for Th2 cell differentiation.
GATA3 also negatively regulates Th1 differentiation. It re-
presses IFN-g production through an IL-4-independent pathway
(Ouyang et al., 1998; Usui et al., 2003). Ouyang et al. (1998)
showed that overexpression of GATA3 in Th1 cells inhibited
IL-12Rb2 expression, which is normally induced under Th1
conditions. However, enforced IL-12Rb2 expression in GATA3-
overexpressing Th1 cells does not restore IFN-g production,
implying that another mechanism, possibly downregulation of
STAT4, contributes to GATA3 repression of Th1 differentiation
(Usui et al., 2003).
Interestingly, GATA3-deficient CD4+ T cells cultured under Th2
conditions produced IFN-g, indicating that endogenous GATA3
is required to actively repress IFN-g production in Th2 cells and
that without GATA3, IFN-g production can be induced in the
absence of the two established Th1-inducing factors, IL-12 and
IFN-g (Pai et al., 2004; Zhu et al., 2004). Furthermore, in
GATA3-conditionally-deficient mice, CD4+ T cells produced
IFN-g in response to Nippostrongylus brasiliensis infection, an
infection that elicits strong Th2 responses in WT mice. We were
intrigued by this finding and became interested in understanding
how GATA3 mediated IFN-g repression. Here, we show that
GATA3 suppresses both STAT4- and T-bet-independent Eomes
expression and IFN-g production. Our results indicate that the
ratio of Runx3 to GATA3 determines the degree of IFN-g expres-
sion. This ‘‘balanced’’ regulation may be explained by the
capacity ofGATA3andRunx3 tobind to eachother. Furthermore,
we show that Runx3 binds tomany critical regulatory elements of
Ifng gene, someofwhich colocalize with T-bet binding sites, sug-
gesting that Runx3 directly regulates IFN-g production.
RESULTS
Deletion of Gata3 Allows IFN-g Production
Independently of IL-12-STAT4 and IFN-g-T-bet
GATA3 is important for CD4+ T cell development in the thymus
and for Th2 cell differentiation in the periphery (Ho et al., 2009).
To investigate the role of GATA3 in T cells at different develop-
mental stages, we generated mice in which exon4 of Gata3 is
flanked by two loxP sites (Gata3fl/fl). Gata3 deletion by CD4-
Cre greatly diminished the development of CD4+ T cells. Of the
few peripheral CD4+ T cells that do appear in such mice, the
majority displayed a memory phenotype (Zhu et al., 2004). We
also reported that deletion of Gata3 by OX40-Cre in activated
T cells abolished Th2 responses to Nippostrongylus brasiliensis
infection and allowed the production of IFN-g by cells from
infected mice. However, the effect of Gata3 deletion in naive
CD4+ T cells has not been previously tested. The expression of
humanized Cre driven by the distal Lck promoter (dLck-Cre Tg,
line 3779) efficiently deletes floxed genes in CD4 or CD8
single-positive T cells in the thymus and naive CD4+ T cells in
the periphery (Zhang et al., 2005). To investigate the function
of GATA3 in naive CD4+ T cells, Gata3fl/fl-dLck-Cre mice were
prepared by crossing Gata3fl/fl mice to dLck-Cre Tg mice.508 Immunity 32, 507–517, April 23, 2010 ª2010 Elsevier Inc.CD4+ and CD8+ T cells developed normally in the thymi of
Gata3fl/fl-dLck-Cre mice and the majority of CD4+ and CD8+
T cells in periphery of these mice displayed a naive phenotype
(CD62LhiCD44lo), in a percentage that was indistinguishable
from that of control mice (Figure S1A available online). The dele-
tion efficiency of the Gata3 gene in CD4+ and CD8+ T cells from
Gata3fl/fl-dLck-Cre mice was approximately 70% and 90%,
respectively (Figure S1B). Thus, unlike Gata3fl/fl-CD4-Cre mice
in which GATA3-deficient naive CD4+ T cells were not present
in substantial numbers because the gene was deleted too early
during T cell development, Gata3fl/fl-dLck-Cre mice provide
a unique opportunity to study the role of GATA3 at early stages
of T cell differentiation from naive CD4+ T cells.
Naive CD4+ T cells were isolated from Gata3fl/fl-dLck-Cre or
Gata3fl/fl mice and then cultured with soluble anti-CD3 and
anti-CD28 in the presence of T-depleted splenocytes under
Th1 (IL-12 and anti-IL-4) or Th2 conditions (anti-IL-12, anti-
IFN-g, and IL-4). Gata3 deletion in Th1 cells did not affect
IFN-g production by these cells (Figure 1A, left panel). As
expected, IL-4 production by these Gata3fl/fl-dLck-Cre ‘‘Th2’’
cells upon stimulation was dramatically lower than that by
controls (31.2% versus 69.9%, Figure 1A, middle panel). IFN-g
production was induced in 24% of the ‘‘Th2’’ cells from
Gata3fl/fl-dLck-Cre mice even though both IL-12 and IFN-g
were neutralized in the culture. Because the deletion of Gata3
by dLck-Cre is incomplete, intracellular staining of GATA3 was
carried out to identify the Gata3-deleted cells (Figure 1A, right
panel). Among the Gata3fl/fl-dLck-Cre ‘‘Th2’’ cells, IL-4 was
produced only by CD4+ T cells from which GATA3 had not
been deleted, whereas IFN-g was produced mainly by CD4+
T cells that had deleted the gene. A substantial amount of
IFN-g was detected by ELISA in the supernatant of Gata3fl/fl-
dLck-Cre ‘‘Th2’’ cells (Figure 1B). Careful kinetic study showed
that IFN-g expression by Gata3fl/fl-dLck-Cre cells cultured
under Th2 conditions, similar to that by WT Th1 cells, was
most prominent at 48 hr after stimulation (data not shown). These
data imply that GATA3 is crucial for the induction of IL-4 produc-
tion and that loss of GATA3 in naive CD4+ T cells allows IFN-g
production when they become activated in the absence of
engagement of both the IL-12-STAT4 pathway and the IFN-g-
STAT1 pathway.
T-bet is the ‘‘master regulator’’ of IFN-g production in Th1 cells
(Szabo et al., 2000). To test whether T-bet is involved in the IFN-g
production in GATA3-deficient ‘‘Th2’’ cells, we generated
Gata3fl/fl-dLck-Cre-Tbx21/ mice deficient in both GATA3 and
T-bet. Whereas 15% of Tbx21/ Th1 cells produced IFN-g,
67% of Gata3fl/fl-dLck-Cre-Tbx21/ Th1 cells did so (Fig-
ure 1C, left panel). Identical to the data shown in Figure 1A,
more than 90% of Gata3fl/fl and Gata3fl/fl-dLck-Cre Th1 cells in
this experiment produced IFN-g (data not shown). Importantly,
25% of Gata3fl/fl-dLck-Cre-Tbx21/ cells cultured under Th2
or neutral conditions (without addition of exogenous cytokines
and antibodies to cytokines) produced IFN-g (Figure 1C, middle
and right panels). Tbx21/ and Gata3fl/fl-dLck-Cre-Tbx21/
were also infected with Nippostrongylus brasiliensis. IL-4 and
IFN-gmRNA were measured by quantitative PCR on day 9 after
infection (Figure 1D). IL-4 expression was dramatically reduced,
and IFN-g expression was enhanced in Gata3fl/fl-dLck-Cre-
Tbx21/ cells compared to Tbx21/ cells. These data indicate
Figure 1. Gata3Deletion fromNaive CD4+ T Cells Results in T-bet-Independent IFN-g Production during Th2 Differentiation both In Vitro and
In Vivo
(A) CD4+ T cells isolated from Gata3fl/fl or Gata3fl/fl-dLck-Cre mice were activated under Th1 or Th2 conditions in the presence of T-depleted splenocytes for 3
days. After cultured with IL-2-containing medium for another 2 days, the cells were restimulated with PMA plus ionomycin for 4 hr. The expression of IL-4, IFN-g,
and GATA3 were measured by intracellular staining. Numbers indicate the percentage in each quadrant.
(B) The amount of IFN-g protein in the supernatants of the cells prepared in (A) that had been restimulated with PMA and ionomycin for 24 hr was measured by
ELISA. Error bars represent means ± SD.
(C) Naive CD4+ T cells isolated from Tbx21/ orGata3fl/fl-dLck-Cre-Tbx21/micewere activated under Th1, Th2, or ThNeutral conditions and analyzed as in (A).
(D) Nine days after N. brasiliensis infection, CD44hiCD62Llo CD4+ T cells were sorted frommesenteric lymph nodes of the infected mice and quantitative RT-PCR
was performed. The relative expression of IL-4 and IFN-gwas normalized by the expression of glyceraldehyde-3-phosphate dehydrogenase (GAPDH). Error bars
represent means ± SD of the data from three individual mice in each group. Data are representative of three independent experiments (A and C).
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GATA3 Suppresses Runx3-Mediated IFN-g Productionthat GATA3 regulates T-bet-independent IFN-g production both
in vitro and in vivo.
Eomes, but Not T-bet, Is Upregulated
in Gata3fl/fl-dLck-Cre ‘‘Th2’’ Cells
To determine how deletion of GATA3 allowed IL-12-IFN-g-inde-
pendent IFNg production in CD4+ T cells, the expression of the
IFNg-inducing transcriptional factors T-bet, Eomes, Runx3,
and STAT4 was assessed by quantitative PCR in both WT and
GATA3-deficient ‘‘Th2’’ cells (Figure 2A). Strikingly, Eomes, but
not T-bet, mRNA was increased in GATA3-deficient ‘‘Th2’’ cells.
Intracellular staining of Eomes and T-bet confirmed that GATA3-
deficient ‘‘Th2’’ cells expressed Eomes, but not T-bet (Fig-
ure 2B). Virtually all the cells that had deleted GATA3 from
Gata3fl/fl-dLck-Cre ‘‘Th2’’ group expressed Eomes, although
only a small proportion of WT Th1 cells expressed this transcrip-
tion factor. Furthermore, GATA3-deficient Th1 cells failed to
express Eomes, suggesting that either Th1 factors inhibit Eomesexpression or IL-4 induces Eomes when GATA3 is absent.
STAT4 was also upregulated in Gata3fl/fl-dLck-Cre ‘‘Th2’’ cells
at both mRNA (Figure 2A) and protein amounts (Figure 2C),
consistent with the previous report that GATA3 suppresses
STAT4 expression in Th2 cells (Usui et al., 2003). Runx3 was
slightly increased at both mRNA and protein levels when
Gata3 was deleted from differentiating Th2 cells; however,
such Runx3 expression is still much lower than its expression
in Th1 cells. Thus, the loss of GATA3 during Th2 differentiation
results in increased expression of Eomes and STAT4, but not
T-bet.
Th1 cells also preferentially express IL-12Rb2 and CXCR3. In
GATA3-deficient ‘‘Th2’’ cells, the expression of IL-12Rb2 was
slightly enhanced, while CXCR3 expression was dramatically
upregulated (Figure S2). Upregulation of STAT4 expression and
a slight increase of IL-12Rb2 could contribute to IFN-g produc-
tion if IL-12 were present; however, IL-12 is not available in the
Th2 cultures and we failed to detect STAT4 phosphorylation inImmunity 32, 507–517, April 23, 2010 ª2010 Elsevier Inc. 509
Figure 2. Increase of Eomes, Runx3, and
STAT4, but Not T-bet, Expression in
Gata3fl/fl-dLck-Cre CD4+ T Cells Differenti-
ated under Th2 Conditions
(A) Total RNAs fromGata3fl/fl orGata3fl/fl-dLck-Cre
CD4+ T cells cultured under Th2 conditions were
prepared. The expression of indicated genes
was measured by quantitative RT-PCR. The rela-
tive expression was normalized by the expression
of GAPDH, and the expression of each gene in WT
Th2 cells was set as ‘‘1.’’ Error bars represent
means ± SD.
(B) Th1 and Th2 cells prepared as in Figure 1A
were stained for intracellular Eomes, T-bet, and
GATA3 expression. Numbers indicate the per-
centage in each quadrant. (C) STAT4 and Runx3
protein expression in the cells prepared in (B)
was measured by immunoblotting. Arrow indi-
cates Runx3 protein. Data are representative of
three independent experiments.
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GATA3 Suppresses Runx3-Mediated IFN-g ProductionGata3fl/fl-dLck-Cre cells cultured under Th2 conditions (data not
shown). Therefore, the upregulation of Eomes is most likely
responsible for IFN-g production in GATA3-deficient ‘‘Th2’’ cells.
Eomes, but Not T-bet, Contributes to the IFN-g
Production in GATA3-Deficient ‘‘Th2’’ Cells
Eomes has been reported to play an important role in IFN-g
production in CD8+ T cells (Pearce et al., 2003). In addition,
Eomes expression in CD4+ T cells may contribute to optimal
IFN-g production by these cells (Suto et al., 2006). To further
address whether Eomes is capable of inducing IFN-g in Th2
cells,WT or Tbx21/CD4+ T cells cultured under Th2 conditions
were infected with an Eomes-GFP-Retrovirus (RV). 30.8% of WT
and 23.5% of Tbx21/ Th2 cells that had been infected with the
Eomes-GFP-RV produced IFN-g (Figure 3A), whereas less than
1% of control-RV infected Th2 cells produced IFN-g. RV-driven
Eomes expression was comparable to endogenous Eomes
expression in GATA3-deficient ‘‘Th2’’ cells (Figure S3), suggest-
ing Eomes in GATA3-deficient ‘‘Th2’’ cells is sufficient to induce
IFN-g production independently of T-bet. Interestingly, enforced
Eomes expression in Th2 cells did not suppress IL-4 production.
To compare the functions of Eomes and T-bet, expression of
mRNA of multiple genes in sorted Th2 cells that had been in-
fected with T-bet- or Eomes-RV was measured by quantitative510 Immunity 32, 507–517, April 23, 2010 ª2010 Elsevier Inc.PCR. Eomes was less potent than T-bet
in inducing IFN-g and IL-12Rb2 and in
suppressing GATA3 expression, how-
ever, it induced CXCR3 to a similar
degree as did T-bet (Figure 3B). Both
T-bet and Eomes are the members of
T-box family and they bind to similar
DNA sequences. A dominant-negative
form of T-bet (T-bet DN) has been
reported to suppress the activities of
both T-bet and Eomes (Mullen et al.,
2002). Infection of ‘‘Th2’’ cells from both
Gata3fl/fl-dLck-Cre and Gata3fl/fl-dLck-
Cre-Tbx21/ mice with T-bet DN-GFP-
RV reduced the percentage of IFN-g-producing cells by a
comparable degree, from 55% to 27% in the former and from
51% to 22% in the latter (Figure 3C), indicating that Eomes is
at least partially responsible for the capacity of cells lacking
GATA3 to produce IFN-g. It also suggests that a non-T-box
family member may be responsible for a portion of the IFN-g
production.
Runx3 Induces IFN-g Production and Eomes Expression
Runx3 is expressed in Th1 cells and is known to induce the
capacity of these cells to produce IFN-g as well as to suppress
their production of IL-4 (Djuretic et al., 2007; Naoe et al., 2007).
Because both Runx3 and Eomes are highly expressed in CD8+
T cells (Egawa et al., 2007; Pearce et al., 2003), we also tested
the involvement of Runx3 in IFN-g production by Th2 cells.
Runx3-GFP-RV transduction into WT Th2 cells resulted in
41.4% of the cells being able to secrete IFN-g (Figure 4A, upper
panel). The acquisition of IFN-g-producing capacity by overex-
pression of Runx3 is independent of T-bet since Tbx21/
Th2 cells that had been infected with the Runx3-GFP-RV
were similar to WT Runx3-GFP-RV-infected cells in their ability
to produce IFN-g (Figure 4A, lower panel). Unlike enforced
Eomes expression, Runx3 expression in Th2 cells dramatically
reduced the frequency of IL-4-producing cells, from 26% to
Figure 3. Eomes, but Not T-bet, Contributes
to the IFN-g Production in Gata3fl/fl-dLck-
Cre ‘‘Th2’’ Cells
(A) CD4+ T cells isolated from WT or Tbx21/
mice were stimulated under Th2 conditions and in-
fected with Eomes-GFP-RV (Eomes-RV) or empty
GFP-RV as a control (Control-RV).
(B) Naive CD4+ T cells isolated WT mice were
stimulated under Th2 conditions and infected
with Control, Eomes, or T-bet-GFP-RV. GFP+
CD4+ T cells from each group were sorted, and
quantitative RT-PCR was performed. The relative
expression was normalized by GAPDH, and the
expression of each gene in Control-RV infected
Th2 cells was set as ‘‘1.’’ Error bars represent
means ± SD.
(C) CD4+ T cells isolated from WT, Gata3fl/fl-dLck-
Cre, or Gata3fl/fl-dLck-Cre-Tbx21/ mice were
stimulated under Th2 conditions and infected
with T-bet-Eomes DN-GFP-RV (a RV containing
a dominant-negative form of T-bet) or Control-
GFP-RV. (A and C) Activated cells were restimu-
lated with PMA plus ionomycin, and intracellular
staining of IFN-g and IL-4 was performed. The
plots were gated on CD4+GFP+ cells. Numbers
indicate the percent of cells in each quadrant or
gate. Data are representative of two independent
experiments.
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GATA3 Suppresses Runx3-Mediated IFN-g Production3.5% in WT and from 21% to 3.8% in Tbx21/ Th2 cells. Thus,
the suppression of IL-4-producing capacity by Runx3 is also
T-bet-independent.
Interestingly, enforced Runx3 expression strongly induced
Eomes mRNA with minimal effects on the expression of T-bet
(Figure 4B) and GATA3 (data not shown). IFN-g production
induced by enforced Runx3 was again partially blocked by
T-bet DN (Figure 4C), suggesting that Runx3 induces IFN-g
production partly through its upregulation of Eomes expression.
Runx3 and T-bet Bind to Multiple Regulatory Elements
of the Ifng Gene
To test whether Runx3 is involved in IFN-g production in Th1
cells, we constructed a dominant-negative Runx3 (Runx3 DN)
based on a previous report (Hayashi et al., 2000). Infecting
normal Th1 cells with Runx3 DN-RV, similar to that with T-bet
DN-RV, dramatically reduced the percentage, as well as the
mean fluorescence intensity (MFI), of the IFN-g-producing cells
(Figure 5A), suggesting optimal IFN-g production in normal Th1
cells requires T-bet, as well as Runx3, function.
To explore the molecular mechanisms underlying these
effects, we performed ChIPseq (chromatin immunoprecipitation
in combination with high throughput deep sequencing) to identify
the binding sites of Runx3 and T-bet in Th1 cells. An antibody to
CBFb, which is a cofactor of Runx complexes, was used since
we failed to identify ChIP quality Runx3 antibody.
The data showed that Runx protein complex weakly binds to
many sites within the Il4-Il13 locus, including DNase I hypersen-
sitivity (HS) IV (Figure S4A), the site to which Runx has been
previously reported to bind. By contrast, T-bet failed to bind to
HS IV, consistent with our data that Runx3-mediated suppres-
sion of IL-4 production does not require T-bet. No apparentbinding clusters for Runx protein complex can be identified in
the vicinity of the Eomes gene (Figure S4B), although there are
clusters of CBFb binding sites at the Eomes neighbor gene
Azi2 (data not shown), suggesting Runx3 may regulate Eomes
expression through a long-distance interaction if such action is
direct or Runx3 indirectly regulates Eomes.
Importantly, both Runx and T-bet strongly bind to many
regulatory elements of the Ifng gene (Figure 5B). The common
binding sites for these two transcription factors are at conserved
noncoding sequence (CNS)34, CNS22, Ifng promoter (HSI)
and CNS+29. In addition, Runx3 uniquely binds to CNS-6,
HSII, HSIII and CNS+55, whereas T-bet uniquely binds to
CNS+18–20 and CNS+46. These data suggest both Runx3 and
T-bet regulate IFN-g production by binding tomany critical regu-
latory elements of the Ifng gene.
GATA3Represses theCapacity of Runx3 to Induce IFN-g
Expression
We have shown here that loss of GATA3 expression in Th2 cells
resulted in the acquisition of IFN-g-producing capacity that was
correlated with Eomes, but not T-bet expression, and that Runx3
overexpression in Th2 cells resulted in IFN-g-producing capacity
and upregulated Eomes. However, the relationship between
GATA3 and Runx3 in regulating Eomes and IFN-g expression
remains unknown.
We first asked whether it appeared that GATA3 and Runx3
acted in a balanced manner. Th2 cells were coinfected with
a Runx3-Thy1.1-RV and a GATA3-GFP-RV. While cells that
were infected with neither virus could produce little IFN-g,
a substantial proportion of the cells infected with Runx3-RV
alone produced IFN-g (23.5%), but this was reversed in cells
that had been infected with both the Runx3 and GATA3-RVsImmunity 32, 507–517, April 23, 2010 ª2010 Elsevier Inc. 511
Figure 4. Runx3 Induces IFN-g Production
and Eomes Expression
(A) CD4+ T cells isolated from WT and Tbx21/
mice were stimulated under Th2 conditions and
infected with Runx3-GFP-RV or Control-GFP-RV.
Infected cells were restimulated and stained as
in Figure 3A. The dot plots were gated on CD4+
GFP+ cells.
(B) CD4+GFP+ cells were isolated by cell sorting
from the cells prepared in (A). RNAswere prepared
from sorted cells, and the expression of Eomes
and T-bet was measured by quantitative RT-
PCR. The expression levels of each gene in
Control-RV infected cells were set as ‘‘1’’.
(C) CD4+ T cells isolated from WT mice were stim-
ulated under Th2 conditions and then coinfected
with Runx3-Thy1.1-RV and T-bet-Eomes DN-
GFP-RV or Control-GFP-RV. Infected cells were
restimulated and stained as in Figure 3A. Numbers
indicate the percent of cells in each quadrant or
gate. Error bars represent means ± SD. Data are
representative of two (B) or three (A and C) inde-
pendent experiments.
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GATA3 Suppresses Runx3-Mediated IFN-g Production(3.5%, Figure 6A). The amount of IFN-g produced by stimulated
doubly-RV-infected cells separated based on the relative inten-
sities of GFP and Thy1.1 expression, representing the relative
expression of GATA3 and Runx3, respectively, correlated with
the ratio of Runx3 and GATA3 expression (Figure 6B). By
contrast, an excess of GATA3 did not prevent Runx3 from sup-
pressing IL-4 production. Consistent with its role in regulating
IFN-g production, Eomes expression was only enhanced in the
cells expressing retroviral Runx3 alone; such induction was
repressed by additional GATA3 expression (Figure 6C). These
results imply that GATA3 suppresses Runx3-mediated Eomes
induction and IFN-g production in a quantitative manner.
A possible explanation for such quantitative regulation would
be that GATA3 could interact with Runx3 and, thus, block its
ability to induce Eomes and IFN-g. Anti-GATA3 immunoprecipi-
tated Runx3 from extracts of primary Th1 cells, indicating an
interaction between these two factors (Figure 7A). To determine
which domains of GATA3 interact with Runx3, we prepared
a series of GATA3 mutants (Figure S5A). HEK293T cells were
singly or cotransfected with expression vectors encoding
Runx3 and WT or mutant GATA3. Deletion of the N terminus or
zinc fingers of GATA3 abolished its binding to Runx3, whereas
a C-terminal deleted GATA3 retained its ability to bind to
Runx3 (Figure 7B). The GATA3 mutants that failed to interact512 Immunity 32, 507–517, April 23, 2010 ª2010 Elsevier Inc.with Runx3 also lost their capacity to
suppress Runx3-mediated IFN-g produc-
tion in Th2 cells (Figure 7C). However,
although the GATA3 C-terminal deletion
mutant was fully capable of suppressing
Runx3-mediated IFN-g production (Fig-
ure 7C), consistent with its ability to bind
to Runx3, it had a substantial reduction
in its ability to induce IL-4 in Th1 cells
(Figure S5B).
To confirm that the IFN-g production by
GATA3-deficient ‘‘Th2’’ cells is Runx3dependent but T-bet independent, we generated triple-deficient
mice,Gata3fl/flRunx3fl/fl -dLck-Cre-Tbx21/ (Figure 7D). Eomes
expressionwasonly slightly reduced in triple-deficientmice, sug-
gesting that there is a Runx3-independentmechanism for Eomes
induction when GATA3 is absent in Th2 cells. However, despite
continued expression of Eomes, the proportion of IFN-g-pro-
ducing cells was dramatically reduced in Gata3fl/fl Runx3fl/fl -
dLck-Cre-Tbx21/ ‘‘Th2’’ cells compared to Gata3fl/fl-dLck-
Cre-Tbx21/ (8% versus 32%) suggesting that Runx3 is
required for the bulk of T-bet-independent IFN-g production in
GATA3-deficient ‘‘Th2’’ cells and that it is the balance between
GATA3 and Runx3 that controls IFN-g production.
DISCUSSION
GATA3 is a crucial transcription factor in the regulation of T
helper cell differentiation. Not only is GATA3 critical for inducing
Th2 differentiation, but it is also essential for repressing Th1
differentiation. It has been reported that GATA3 represses the
IL-12-STAT4-IFN-g pathway during Th2 differentiation through
multiple mechanisms, including the suppression of both IL-
12Rb2 and STAT4 (Ouyang et al., 1998; Usui et al., 2003).
Here, by using a mouse line carrying a Cre transgene that condi-
tionally deletes Gata3 in naive CD4+ T cells, we demonstrated
Figure 5. Runx3 Is Important for Optimal IFN-g Production by Th1
Cells, and It Binds to Many Regulatory Elements Located in Ifng
Locus
(A) WT CD4+ T cells were stimulated under Th1 conditions and infected with
Runx3 DN-GFP-RV, T-bet-Eomes DN-GFP-RV, or Control-GFP-RV. Infected
cells were restimulated and stained as in Figure 3A. The black lines represent
CD4+GFP+ cells, and the shaded area represents CD4+GFP cells in the same
culture.
(B) WT Th1 cells were harvested and fixed. ChIPSeq analysis was performed
using specific antibody against CBFb or T-bet. The sequence tags mapped
to the locus of Ifng are shown. Critical Runx and T-bet binding elements cor-
responding to DNase I hypersensitivity (HS) sites, and conserved noncoding
sequences (CNS) are highlighted.
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GATA3 Suppresses Runx3-Mediated IFN-g Productionthat GATA3 actively suppresses IFN-g production even in the
presence of IL-4, anti-IL-12, and anti-IFN-g. Without GATA3,
the expression of STAT4 is increased, but only a modest
increase of IL-12Rb2 mRNA expression was noted. IL-12Rb2
expression can be regulated by the IL-12-STAT4 and the IFN-
g-T-bet pathways (Afkarian et al., 2002; Lawless et al., 2000;
Ouyang et al., 1998). Thus, during Th1 differentiation in the pres-
ence of IL-12, the direct target suppressed by enforcedGATA3 is
likely to be STAT4, and through regulating the IL-12-STAT4
pathway, GATA3 indirectly affects IL-12Rb2, IFN-g, and T-bet
expression.
In this report, we describe Runx3-Eomes-mediated IFN-g
production in GATA3-deficient ‘‘Th2’’ cells. Such IFN-g produc-
tion is IL-12-STAT4 and IFN-g-T-bet independent. The expres-
sion of Eomes, but not T-bet, is enhanced in GATA3-deficient
CD4+ T cells cultured under Th2 conditions, where both IL-12
and IFN-g are neutralized. Enforced Eomes expression during
Th2 differentiation induces the capacity of these cells to produce
IFN-g in the absence of T-bet. Moreover, GATA3 single-deficient
and GATA3-T-bet double-deficient CD4+ T cells cultured under
Th2 conditions produce similar amount of IFN-g. Such IFN-g
production is inhibited by T-bet DN, which has been reportedto suppress the function of both T-bet and Eomes (Pearce
et al., 2003). Although the inhibition of IFN-g production by
T-bet DN is only partial, the data clearly imply that Eomes, not
T-bet, contributes to IFN-g production in GATA3-deficient
‘‘Th2’’ cells. We have reported earlier that in Gata3-deleted
‘‘Th2’’ clones, T-bet expression was elevated (Zhu et al., 2006).
Because these clones had been cultured for a long period of
time, it is possible that the large amount of IFN-g produced by
these clones in the culture was not completely neutralized and
that IFN-g was responsible for T-bet induction.
Expressing Runx3 in activated CD4+ T cells cultured under Th2
conditions strongly suppresses IL-4 production. Although others
have argued that the suppression of IL-4 by Runx3 requires
T-bet (Djuretic et al., 2007), our results clearly demonstrate the
suppression of IL-4 by Runx3 is as efficient in T-bet-deficient
Th2 cells as in WT cells. In addition, the ChIPseq data show
that the Runx protein complex, but not T-bet, binds to the HS
IV site of the Il4 locus in Th1 cells. However, T-bet, but not
Runx3, suppresses GATA3 expression. Thus, Runx3 and T-bet
can collaborate in repressing IL-4 production through two
different mechanisms—Runx3 directly suppresses IL-4 and
T-bet indirectly affects IL-4 by repressing GATA3.
Besides suppressing IL-4 production, Runx3 induces IFN-g
production in Th2 cells correlated with strong induction of
Eomes, but not T-bet. Although there is only a slight increase
of Runx3 expression when GATA3 is absent, deletion of Runx3
from GATA3-T-bet double-deficient cells results in dramatic
decrease in IFN-g production, indicating that Runx3 is needed
for IFN-g production in these cells. However, deletion of Runx3
from GATA3-T-bet double-deficient cells only causes a modest
decrease in Eomes expression, suggesting Runx3 is redundant
for Eomes induction in GATA3-deficient ‘‘Th2’’ cells. Further-
more, although Runx3 is highly expressed in Th1 cells, only
a small percentage of these cells express Eomes even when
GATA3 is deleted, suggesting that Runx3 is not sufficient to
induce Eomes expression in a Th1 environment. Whether the
Eomes-expressing CD4+ T cells represent a unique lineage of
Th cells needs to be further studied. Nevertheless, it has been
recently reported that CD8+ T cells, in which GATA3 is underex-
pressed, have adopted the Runx3-Eomes pathway for their
optimal IFN-g production (Cruz-Guilloty et al., 2009).
Runx3 is highly expressed in Th1 cells and enforced expres-
sion of Runx3 DN in Th1 cells results in diminished IFN-g produc-
tion, consistent with an earlier report that Runx3 regulates IFN-g
production (Djuretic et al., 2007). Here, we show Runx3-medi-
ated IFN-g production can be blocked by GATA3. Furthermore,
by using ChIPseq, we show that, in normal Th1 cells, the Runx
protein complex binds to multiple critical regulatory elements
of Ifng gene, some of which are also bound to T-bet. STAT4
has also been reported to directly bind to the Ifng gene. There-
fore, optimal IFN-g production and Th1 differentiation involves
three pathways: IL-12-STAT4-, IFN-g-T-bet-, and Runx3-medi-
ated pathways. Each pathway makes some contribution to
IFN-g production through direct action on the Ifng gene, and
there is also crosstalk among these pathways. For example,
STAT4 and T-bet have a synergistic effect on inducing IFN-g
production; Runx3 and T-bet can interact with each other
and bind to many sites in Ifng locus; T-bet may be responsible
for upregulating Runx3 expression; IL-12-STAT4 is partiallyImmunity 32, 507–517, April 23, 2010 ª2010 Elsevier Inc. 513
Figure 6. GATA3 Represses Runx3-Medi-
ated IFN-g Production and Eomes Induction
(A and B) WT CD4+ T cells were stimulated under
Th2 conditions and coinfected with GATA3-GFP-
RV and Runx3-Thy1.1-RV. Infected cells were
restimulated and stained as in Figure 3A. The dot
plots were gated based on the expression of
GFP and Thy1.1 (A). Nine subsets (1 through 9)
expressing different amount of GFP and Thy1.1
were selected for further analysis (B, left panel).
The percentages of IL-4 or IFN-g-producing cells
from these nine subsets were plotted (B, right
panel).
(C) WT CD4+ T cells were stimulated and infected
as in (A). Infected cells were sorted based on
the expression of GFP and Thy1.1. RNAs were
prepared from sorted cells, and the expression
of Eomes was measured by quantitative RT-PCR.
The relative expression of Eomes in Control-
Thy1.1+ and Control-GFP+ cells was set as ‘‘1’’.
Error bars represent means ± SD. Data are repre-
sentative of three (A and B) and two (C) indepen-
dent experiments.
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GATA3 Suppresses Runx3-Mediated IFN-g Productionresponsible for T-bet upregulation; and T-bet downregulates
GATA3 during Th1 differentiation, resulting in the upregulation
of STAT4, as well as the release of the inhibition of Runx3-
mediated IFN-g production. Our finding of GATA3 regulating
Runx3 function and STAT4, but not T-bet, expression increases
our understanding on the cross-regulation of Th1 versus Th2
differentiation.
We also show that GATA3 physically interacts with Runx3 in
primary T cells and the level of IFN-g production strongly corre-
lates with the ratio of Runx3 to GATA3. The N terminus and zinc
fingers, but not C terminus, of GATA3 are required for the
interaction with Runx3. The GATA3 mutant with the C-terminal
deletion substantially loses its ability to induce IL-4, but is fully
functional in suppressing Runx3-mediated IFN-g production,
suggesting that the positive and negative functions of GATA3
can be separated. This may be critical for guiding effective
immune intervention strategies in treating Th1- and Th2-related
diseases.
Two reports previously suggest that the association of tran-
scription factors dominant in different Th lineages can mutually514 Immunity 32, 507–517, April 23, 2010 ª2010 Elsevier Inc.regulate their functions (i.e., T-bet and
GATA3; Foxp3 and RORgt) (Hwang
et al., 2005; Zhou et al., 2008). Here, we
reported a third example of such mutual
regulation between GATA3 and Runx3
during Th1-Th2 differentiation. Since
both GATA3 and Runx3 are also critical
during CD4 versus CD8 lineage commit-
ment in thymus (Bosselut, 2004; Herna´n-
dez-Hoyos et al., 2003; Pai et al., 2003;
Sato et al., 2005; Setoguchi et al., 2008;
Taniuchi et al., 2002), the interaction and
cross-regulation of these two molecules
may also play a role in determining CD4-
CD8 fate in the thymus, a subject that
needs to be further studied.In conclusion, we show that Runx3 directly bound to many
critical regulatory elements at the Ifng locus and induced IFN-g
expression even in the absence of T-bet. GATA3 suppressed
Runx3-mediated IFN-g production through protein-protein inter-
actions. Therefore, the relative amount of GATA3 and Runx3
expression plays a role in regulating Th1 versus Th2 responses.
EXPERIMENTAL PROCEDURES
Animals
Mice carrying dLck-Cre transgene (line 3779), Runx3fl/fl mice, and Gata3fl/fl
mice were previously reported (Naoe et al., 2007; Zhang et al., 2005; Zhu
et al., 2004). Tbx21/ mice (line 4648) were obtained from the Jackson labo-
ratory (Finotto et al., 2002). All mice were bred and maintained under specific
pathogen-free conditions in the National Institute of Allergy and Infectious
Diseases (NIAID) animal facility and used at 5–12 weeks of age under an
approved protocol according to the NIAID guidelines for animal care.
Preparation of Cells
CD4+ T cells were isolated from lymph nodes by negative selection as previ-
ously described (Yamane et al., 2005), except when autoMACS (Miltenyi
Biotec) was used. For purification of naive CD4+ T cells, CD44loCD62Lhi
Figure 7. Runx3 Protein Interacts with GATA3 Protein, and Runx3 is Responsible for IFN-g Production in GATA3-Deficient ‘‘Th2’’ Cells
(A) Total Th1 cell lysates were immunoprecipitated with anti-GATA3 or isotype antibody and then immunoblotted with anti-Runx polyclonal Ab. The membrane
was then stripped and reblotted with GATA3 mAb. The cell lysates passed the IP columns were also blotted with anti-Runx as a loading control.
(B) Runx3-RV and Myc-tagged WT or mutant GATA3-RV were cotransfected into HEK293T cells as indicated. Total cell lysates or anti-GATA3-immunoprecip-
itated cell lysates were blotted with anti-Runx or anti-Myc.
(C)WTCD4+ T cells were stimulated under Th2 conditions and coinfected with Runx3-GFP-RV andWT ormutant GATA3-Thy1.1-RV. Infected cells were restimu-
lated and stained as in Figure 3A. The percentage of IFN-g-producing cells in each CD4+GFP+ group was plotted.
(D) CD4+ T cells isolated fromWT,Gata3fl/fl-dLck-Cre-Tbx21/, orGata3fl/flRunx3fl/fl dLck-Cre-Tbx21/mice were activated under Th2 conditions as shown in
Figure 1A. Theywere then stained for intracellular IL-4, IFN-g, and Eomes expression. Numbers indicate the percentage in each quadrant. Data are representative
of two independent experiments.
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splenocytes were prepared by incubation with anti-Thy1.2 mAb supernatant
and rabbit complement (Cedarlane Laboratories Limited) at 37C for 45 min,
followed by irradiation at 30 Gy (3,000 rad). In some experiments, mice were
injected subcutaneously with 500 third-stage infectious larvae ofN. brasiliensis
(Zhu et al., 2004). On day 9 after N. brasiliensis infection, CD4+CD44hiCD62Llo
T cells from mesenteric lymph nodes were sorted by FACSAria.
Activation of T Cells
CD4+ T cells were cultured with irradiated T cell-depleted splenocytes in the
presence of 1 mg/ml of anti-CD3 (145-2C11) and 3 mg/ml of anti-CD28 (37.51)
for 3 days with various combinations of antibodies and cytokines: for Th1
conditions, 10 ng/ml of IL-12 and10mg/ml anti-IL-4 (11B11); for Th2conditions,
5000 U/ml of IL-4, 10 mg/ml anti-IL-12 (C17.8) and anti-IFN-g (XMG1.2); and for
ThNeutral conditions, no additional cytokines or antibodies added. The acti-
vated cells were then cultured in IL-2 (50 U/ml)-containing medium.
Retroviral Constructs and Infection
Eomes-GFP-RV and T-bet DN-GFP-RV constructs were previously described
(Pearce et al., 2003). Runx3 and Gata3 cDNA were cloned from Th1 and Th2cells, respectively, by PCR. The details for the construction of the Runx3-
RV, GATA3-RV, Runx3 DN-RV, and mutant GATA3-RV are described in
Supplemental Experimental Procedures. Retroviruses were prepared by
transfecting Phoenix-Eco packaging cell line with RV constructs using
Fugene6 (Roche) as previously described (Zhu et al., 2004) and were concen-
trated from the culture supernatant by centrifugation at 12,000 g for 14–18 hr at
4C. CD4+ T cells were stimulated with T cell-depleted splenocytes for 24 hr in
the presence of anti-CD3 and anti-CD28 mAbs under Th1 or Th2 conditions
and then infected with concentrated RV as previously described (Zhu et al.,
2004). In some experiments, on day 4, RV-infected cells were sorted based
on the expression of GFP and/or Thy1.1.
RNA Purification and Quantitative PCR
Total RNAs were isolated using a combination of TRIzol (Invitrogen) and
RNeasy Kit (QIAGEN). cDNAs were prepared using SuperScript III Reverse
Transcriptase (Invitrogen). Quantitative PCR was performed on a 7900HT
Sequence Detection System (Applied Biosystems) using the following prede-
signed primer-probe sets: IL-4, IFN-g Eomes, T-bet, STAT4, IL-12Rb2,
CXCR3, and GAPDH (all purchased from Applied Biosystems) and GATA3,
as previously described (Zhu et al., 2004). Primers and probe for detectingImmunity 32, 507–517, April 23, 2010 ª2010 Elsevier Inc. 515
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GATA3 Suppresses Runx3-Mediated IFN-g Productiondistal Runx3 are as follows: 50-TCCAACAGCATCTTTGACTCCTT-30, 50-GGTG
CTCGGGTCTCGTATGA-30, and50-FAM-CCCAACTATACACCAACC-MGB-30.
The efficiency ofGata3 deletion was determined by quantitative PCR, as previ-
ously described (Zhu et al., 2004).Intracellular Staining
Intracellular staining was performed as previously described (Zhu et al., 2004).
In brief, the activated cells maintained in IL-2-containing medium for 1–3 days
were restimulated with 10 ng/ml phorbol 12-myristate 13-acetate (PMA)
and 500 nM ionomycin in the presence of 2 mM monensin for 4 hr. At the
end of stimulation, cells were stained with anti-CD4 and anti-Thy1.1, washed
and fixed with 4% paraformaldehyde for 10 min at room temperature, and
permeabilized in PBS containing 0.5% Triton X-100 and 0.1% BSA. They
were then stained for cytokines and analyzed by FACSCalibur or LSR II (BD
Biosciences), and results were analyzed using FlowJo software (Tree Star).
Staining of the transcription factors was carried out with Foxp3 Staining Buffer
Set (eBioscience) according to the manufacturer’s instructions. Anti-GATA3
(L50-823), anti-T-bet (4B10), and anti-Eomes (Dan11mag) were purchased
from BD Biosciences and e-Biosciences, respectively.ChIPseq Analysis
53 106 cells CD4+ T cells that have been cultured under Th1 conditions for two
rounds, with each round consisting of 4 day TCR stimulation and 2 day culture
in IL-2-containing medium, were cross-linked with formaldehyde, and the
chromatin was sonicated into small fragments. Then the fragmented chro-
matin was immunoprecipitated with specific antibodies. Anti-CBFbwas kindly
provided by Dr. I. Taniuchi. T-bet antibody (4B10) was purchased from Santa
Cruz. The ChIP DNA fragments with a size of 200 bp were treated and
sequenced using the Illumina-Solexa 1G Genome Analyzer, as previously
described (Barski et al., 2007). Sequence reads originating in 200 bp windows
were summed and displayed as custom tracks on the UCSC Genome
Browser.Immunoprecipitation and Immunoblotting
CD4+ T cells activated under Th1 or Th2 conditions for 4 to 5 days were used
for immunoprecipitation and/or immunoblotting. In some experiments, RV
constructs containing Runx3, WT, and mutant GATA3 cDNAs were trans-
fected into HEK293T cells using Fugene6, and these cells were harvested 2
days after transfection. The details of immunoprecipitation and immunoblot-
ting are described in Supplemental Experimental Procedures.SUPPLEMENTAL INFORMATION
The Supplemental Information includes five figures and Supplemental Exper-
imental Procedures and can be found with this article online at doi:10.1016/j.
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